NCT05411471 Immunogenicity and Safety Study of Booster Vaccine With the COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain Status COMPLETED Phase PHASE2
NCT05411458 Effects of Telerehabilitative Aerobic and Relaxation Exercises Patients With Type 2 Diabetes With and Without COVID-19 Status COMPLETED Phase NA
NCT05409300 Evaluation of the Immunogenicity and Safety BBIBP-CorV Vaccine for COVID-19 in Adults in Guinea Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05409261 Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05409170 The Change of Clinical Features and Surgical Outcomes in Patients With Pressure Injury During the COVID-19 Pandemic: A Retrospective Study Status COMPLETED Phase N/A
NCT05408481 Relation Between COVID-19 Pts and Hyponatremia in Adreno Ortical Insufficient Patients. Status UNKNOWN Phase N/A
NCT05408325 Intercellular Adhesion Molecule-1 and TNF-α in Patients With COVID-19 Status COMPLETED Phase N/A
NCT05405296 Evaluation of the Truenat™MTB Plus/COVID-19 Test for TB (Tuberculosis) and COVID-19 (SARS-CoV2) Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05403463 The Effect of Covid-19 on the Disease Course of Multiple Sclerosis :Belgian Lessons Learned From Rocky I to Rocky IV Status COMPLETED Phase N/A
NCT05403359 StEroids in hospitaLized patiEnts With Covid-19 in The Netherlands. Status COMPLETED Phase N/A
NCT05403307 A Real-world Evidence Study of BNT162b2 mRNA Covid-19 Vaccine Among Children in Brazil Status COMPLETED Phase N/A
NCT05401773 α-synuclein Seeding Activity in the Olfactory Mucosa in COVID-19 Status COMPLETED Phase NA
NCT05398965 Eucalyptus Oil as Adjuvant Therapy for Coronavirus Disease 19 (COVID-19) Status COMPLETED Phase PHASE2
NCT05398939 Impact of COVID-19 Vaccination on Serum 25-hydroxyvitamin D Level Status COMPLETED Phase N/A
NCT05398926 Immunogenicity and Safety of a Third Dose of COVID-19 Vaccine(Vero Cell), Inactivated in the Elderly Status COMPLETED Phase PHASE4
NCT05398848 Efficacy, Safety and Immunogenicity Study of the Recombinant Two-component COVID-19 Vaccine (CHO Cell)(Recov) Status COMPLETED Phase PHASE3
NCT05398718 Study on Sotrovimab and Its Impact on the Immune Response to COVID-19 Infection in Real-life in the UAE and Bahrain Status UNKNOWN Phase N/A